• $7.8B
    Market Cap
  • 146.28%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
03/31/2026
03/31/2025
03/31/2024
03/31/2023
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
24.9M
+229.22%
7.6M
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
-100.00%
24.9M
+229.22%
7.6M
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-456.7M
+26.53%
-360.9M
+69.50%
-212.9M
+25.06%
-170.3M
+67.23%
Depreciation and Amortization Expense
409,000
+8.49%
377,000
+63.20%
231,000
+19.69%
193,000
+53.17%
Total Operating Expenses
532.9M
+21.62%
438.2M
+54.98%
282.7M
+29.52%
218.3M
+39.89%
Operating Profit
-505.4M
+22.39%
-412.9M
+59.58%
-258.8M
+22.67%
-211.0M
+34.52%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
2.2M
+363.06%
471,000
+146.73%
-1.0M
+298.42%
-253,000
-67.61%
Income before Taxes
-505.4M
+22.39%
-412.9M
+59.58%
-258.8M
+22.67%
-211.0M
+34.52%
Income Taxes
215,000
-75.87%
891,000
+57.14%
567,000
+6,200.00%
9,000
+110.71%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-505.6M
+22.17%
-413.8M
+59.58%
-259.3M
+22.93%
-211.0M
+34.60%
Net Income from Continuing Operations Applicable to Common
-505.4M
+22.39%
-412.9M
+59.58%
-258.8M
+22.67%
-211.0M
+34.52%
Basic EPS and Net Income
-2.77
+1.47%
-2.73
+45.21%
-1.88
+9.94%
-1.71
+19.58%
Diluted EPS and Net Income
-2.77
+1.47%
-2.73
+45.21%
-1.88
+9.94%
-1.71
+19.58%
Basic Weighted Average Shares
182.4M
+20.35%
151.6M
+9.76%
138.1M
+12.21%
123.1M
+12.21%
Diluted Weighted Average Shares
182.4M
+20.35%
151.6M
+9.76%
138.1M
+12.21%
123.1M
+12.21%
Balance Sheet
Cash and Cash Equivalents
902.1M
+26.35%
714.0M
+12.37%
635.4M
+68.74%
376.5M
-23.75%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
902.1M
+26.35%
714.0M
+12.37%
635.4M
+68.74%
376.5M
-23.75%
Total Current Assets
948.8M
+23.60%
767.7M
+15.30%
665.8M
+64.66%
404.3M
-21.17%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
443,000
-47.51%
844,000
+82.68%
462,000
+38.74%
333,000
+0.91%
Total Long-Term Assets
7.7M
+0.81%
7.6M
+1,548.92%
462,000
+38.74%
333,000
+0.91%
Total Assets
957.0M
+23.29%
776.2M
+16.49%
666.4M
+64.19%
405.8M
-21.28%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
350,000
+104.68%
Total Current Liabilities
104.4M
+51.83%
68.8M
+41.49%
48.6M
+12.27%
43.3M
-2.75%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
0
-100.00%
47,000
-96.14%
Total Liabilities
104.4M
+51.83%
68.8M
+41.49%
48.6M
+12.14%
43.3M
-5.24%
Retained Earnings
-1.7B
+40.79%
-1.2B
+50.12%
-825.7M
+45.79%
-566.3M
+59.36%
Total Stockholders Equity
852.6M
+20.52%
707.4M
+14.52%
617.8M
+70.42%
362.5M
-22.84%
Total Shares Outstanding
203.9M
+19.89%
170.1M
+16.85%
145.6M
+11.70%
130.3M
+11.89%
Cash Flow
Cash from Operating Activities
-407.3M
+8.36%
-375.9M
+75.46%
-214.2M
+13.83%
-188.2M
+77.35%
Capital Expenditures
8,000
-98.95%
759,000
+110.83%
360,000
+82.74%
197,000
-22.44%
Cash from Investing Activities
-8,000
-98.95%
-759,000
+110.83%
-360,000
+82.74%
-197,000
-22.44%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
595.8M
+31.08%
454.5M
-3.80%
472.4M
+566.47%
70.9M
-64.58%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
-1,037.23%
-62.74%
-2,783.73%
N/A
Return on Assets
-58.34%
+1.69%
-57.37%
+18.61%
-48.37%
+5.64%
-45.79%
+35.57%
Return on Equity
-64.82%
+3.78%
-62.46%
+18.04%
-52.91%
+4.38%
-50.69%
+39.29%
Revenue Growth
N/A
N/A
N/A
N/A
229.22%
N/A
N/A
N/A
Current Ratio
9.09
-18.59%
11.16
-18.51%
13.70
+46.67%
9.34
-18.95%
Cash Ratio
8.64
-16.78%
10.38
-20.58%
13.07
+50.30%
8.70
-21.60%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow